Commonwealth Equity Services
RIGL icon

Commonwealth Equity Services’s Rigel Pharmaceuticals RIGL Stock Holding History

Commonwealth Equity Services’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,349
Closed -$20K – 4083
2023
Q4 		$20K Buy
+1,349
New +$13.8K ﹤0.01% 3817

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Commonwealth Equity Services's RIGL Position: Q1 2024 in Review

Commonwealth Equity Services sold out of Rigel Pharmaceuticals (RIGL) in Q1 2024, closing a stake of 1,349 shares — an estimated $20K sold.

Commonwealth Equity Services first reported a position in RIGL in Q4 2023 and held it in 1 quarter. The position peaked at $20K in Q4 2023. 117 funds tracked by Wall St. Rank hold RIGL as of Q1 2024.

  • Commonwealth Equity Services reported no remaining Rigel Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,349 Rigel Pharmaceuticals shares in Q1 2024, an estimated $20K.
  • Commonwealth Equity Services first reported a position in Rigel Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Commonwealth Equity Services's Rigel Pharmaceuticals position peaked at $20K in Q4 2023.
  • 117 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2024.

Based on Commonwealth Equity Services's 13F filing for Q1 2024, filed 29 Apr 2024.